|
|
See Category: Diseases of the musculoskeletal system and connective tissue
See Header: Dermatopolymyositis, unspecified
ICD-10 (CM) Code and Descriptor
|
M33.92 |
Dermatopolymyositis, unspecified with myopathy
|
M3392 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 57.07%
|
20.15%
|
9.01%
|
4.26%
|
4.01%
|
2.38%
|
0.75%
|
0.13%
|
0.50%
|
0.13%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for M33.92*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
165
|
165
|
|
82550
|
ASSAY OF CK (CPK) |
152
|
152
|
|
80053
|
COMPREHEN METABOLIC PANEL |
133
|
133
|
|
96365
|
THER/PROPH/DIAG IV INF INIT |
128
|
128
|
|
96366
|
THER/PROPH/DIAG IV INF ADDON |
128
|
367
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
119
|
119
|
|
J1459
|
INJ IVIG PRIVIGEN 500 MG |
112
|
8,920
|
|
97116
|
GAIT TRAINING THERAPY |
110
|
145
|
|
86140
|
C-REACTIVE PROTEIN |
94
|
94
|
|
85652
|
RBC SED RATE AUTOMATED |
89
|
89
|
|
97110
|
THERAPEUTIC EXERCISES |
89
|
127
|
|
J1569
|
GAMMAGARD LIQUID INJECTION |
75
|
4,960
|
|
96375
|
TX/PRO/DX INJ NEW DRUG ADDON |
68
|
78
|
|
82085
|
ASSAY OF ALDOLASE |
62
|
62
|
|
G0283
|
ELEC STIM OTHER THAN WOUND |
56
|
56
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
54
|
54
|
|
A9270
|
NON-COVERED ITEM OR SERVICE |
46
|
127
|
|
97530
|
THERAPEUTIC ACTIVITIES |
41
|
47
|
|
J2920
|
METHYLPREDNISOLONE INJECTION |
40
|
55
|
|
J1642
|
INJ HEPARIN SODIUM PER 10 U |
31
|
1,550
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
M33.92 related to the following DRG Codes:
545-547
|
